National Health Investors Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of National Health Investors Inc (NHI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: National Health Investors Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 432M vs 29,168M combined for its competitors (1.5% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+12.3% annualized vs trailing 12 months), vs holding steady (+0.5%) for its tracked peer group.
- Growth: National Health Investors Inc generated 33.8% revenue growth year over year in Q2 2026, vs 21.6% for its competitors combined.
- Profitability: Its 45.6% net margin compares with 16.3% for the peer group.
- Scale: National Health Investors Inc ranks #71 of 188 companies by market capitalization in the Real Estate Investment Trusts industry, holding 0.2% of industry market cap.
- Peer revenue share: National Health Investors Inc accounted for 1.6% of combined revenue among its tracked peer group, up from 1.5% a year earlier.
- Peer differentiation: Revenue per employee of $13.50M compares with $13.11M for the peer group (1.0x).
- Structure: National Health Investors Inc operates in the following segments: Real Estate Investment, Senior Housing Operating Portfolio.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
NHI Sales vs. its Competitors, Q2 2026
National Health Investors Inc reported revenue growth of 33.81 % year on year in Q2 2026, above its competitors' combined revenue growth of 21.56 %.
With a net margin of 45.63 %, National Health Investors Inc achieved higher profitability than its competitors (16.25 %).
National Health Investors Inc generated 1.63 % of the combined sales of its peer group, up from 1.48 % a year earlier.
API endpoints for this dataset
National Health Investors Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in National Health Investors Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across National Health Investors Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| National Health Investors Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (10) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across National Health Investors Inc's competitor groups requires a Commercial License.
For context: the Real Estate Investment Trusts industry grew revenue -1.0% year over year, combined, vs 33.8% for National Health Investors Inc. National Health Investors Inc's share of combined industry revenue moved from 0.12% to 0.16%, a gain of 0.04 percentage points.
National Health Investors Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| National Health Investors Inc | Yes | Yes | Yes | No |
| Competitors combined (15) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 87.50 % (7 of 8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
NHI Stock Performance relative to its Competitors
NHI Stock Performance relative to Similar-Size Competitors
NHI Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Northstar Healthcare Income Inc | 282.9% | Outperformed |
| 2 | Welltower Inc | 282.9% | Outperformed |
| 3 | Ltc Properties Inc | 282.9% | Outperformed |
| 4 | Ventas inc | 282.9% | Outperformed |
| 5 | American Healthcare Reit Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for National Health Investors Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
National Health Investors Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of National Health Investors Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 National Health Investors Inc |
3,262.96 | 432.12 |
 Welltower Inc |
184,887.07 | 13,793.30 |
 Ventas inc |
46,171.12 | 6,784.37 |
 Omega Healthcare Investors Inc |
15,297.01 | 1,282.01 |
 Healthpeak Properties Inc |
14,098.01 | 2,872.58 |
 American Healthcare Reit Inc |
11,368.85 | 2,502.04 |
| SUBTOTAL | 303,787.44 | 33,069.22 |
Sign in to see all competitors of National Health Investors Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on National Health Investors Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
National Health Investors Inc's Competitors Named by the Company
Competitive relationships identified from National Health Investors Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Two | Company report | 85% |
| National Healthcare Properties Inc | Company report | 85% |
| Healthpeak Properties Inc | Company report | 85% |
| Ventas inc | Company report | 85% |
| Omega Healthcare Investors Inc | Company report | 85% |
| Ltc Properties Inc | Company report | 85% |
| Welltower Inc | Company report | 85% |
| Caretrust Reit Inc | Company report | 85% |
| Sabra Health Care Reit Inc | Company report | 85% |
| Community Healthcare Trust inc | Company report | 85% |
| Strawberry Fields Reit Inc | Company report | 85% |
| Chiron Real Estate Inc | Company report | 85% |
| American Healthcare Reit Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for National Health Investors Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
National Health Investors Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| National Health Investors Inc | Real Estate Investment 63.09 % |
| Welltower Inc | Senior Housing - Operating 84.10 % |
| Ventas inc | Senior Housing Operating Portfolio (shop) 79.20 % |
| Omega Healthcare Investors Inc | Triple Net Investments 90.95 % |
| Healthpeak Properties Inc | Outpatient medical 42.26 % |
| American Healthcare Reit Inc | Integrated senior health campuses 71.98 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for National Health Investors Inc .
National Health Investors Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| National Health Investors Inc | 3,263 | 13,503,719 | 5,168,438 |
| Welltower Inc | 184,887 | 19,372,612 | 2,454,900 |
| Ventas inc | 46,171 | 12,517,280 | 500,998 |
| Omega Healthcare Investors Inc | 15,297 | 18,579,841 | 12,973,507 |
| Healthpeak Properties Inc | 14,098 | 6,989,234 | 609,779 |
| American Healthcare Reit Inc | 11,369 | 20,678,025 | 1,012,975 |
| PEERS TOTAL | 300,524 | 13,112,535 | 1,917,740 |
Sign in to see all peers for National Health Investors Inc .
National Health Investors Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Welltower Inc | United States 60.91 % |
| American Healthcare Reit Inc | US 99.66 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
National Health Investors Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 181 companies in National Health Investors Inc's industry classification, broader than the peer set above. Market cap in millions of $.National Health Investors Inc ranks #71 of 181 companies by market capitalization in its industry, holding 0.22 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 414, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Welltower Inc | 180,736 | 11.93 % |
| 2 | Prologis Inc | 123,739 | 8.17 % |
| 3 | Equinix Inc | 104,674 | 6.91 % |
| 4 | American Tower Corporation | 87,317 | 5.77 % |
| 5 | Simon Property Group inc | 1,234 | 5.2% |
| 6 | Digital Realty Trust Inc | 1,234 | 5.2% |
| 7 | Public Storage | 1,234 | 5.2% |
| 8 | Realty Income Corporation | 1,234 | 5.2% |
| 9 | Ventas inc | 1,234 | 5.2% |
| 10 | Crown Castle Inc | 1,234 | 5.2% |
| 71 | National Health Investors Inc | 3,263 | 0.22 % |
Market cap and industry share for the rest of National Health Investors Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-10.
National Health Investors Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 66 | Sl green Realty corp | 3,594 | 0.89 % |
| 67 | Broadstone Net Lease Inc | 3,566 | -1.68 % |
| 68 | Lxp Industrial Trust | 3,554 | - |
| 69 | Independence Realty Trust Inc | 3,536 | -9.05 % |
| 70 | Highwoods Properties Inc | 1,234 | 12.3% |
| 71 | National Health Investors Inc | 3,263 | -12.40 % |
| 72 | Corecivic Inc | 1,234 | 12.3% |
| 73 | Diamondrock Hospitality Co | 1,234 | 12.3% |
| 74 | Pebblebrook Hotel Trust | 1,234 | 12.3% |
| 75 | Acadia Realty Trust | 1,234 | 12.3% |
| 76 | Mfa Financial inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of National Health Investors Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-10. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
National Health Investors Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Real Estate Investment Trusts industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (283 companies). See the full Real Estate Investment Trusts industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 0.00 % | 41.74 % (avg) | -41.7 pp |
| Operating Margin | 32.27 % | industry median | +5.2 pp |
| EBITDA Margin | 60.79 % | 38.37 % (avg) | +22.4 pp |
| Capital Intensity (Capex / Revenue) | 86.31 % | 28.42 % (avg) | +57.9 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
National Health Investors Inc's Valuation vs Competitive Position
Valuation multiples vs the Real Estate Investment Trusts industry average (283 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Real Estate Investment Trusts industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 22.1x | 30.1x | -8.0x |
| EV / EBITDA | 18.6x | 17.6x | +1.0x |
| P/B | 2.4x | 1.9x | +0.6x |
| Return on Equity | 10.81 % | industry aggregate | 5.21 % |
| Return on Invested Capital | 3.42 % | 2.09 % (avg) | 1.33 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
National Health Investors Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 5.72 % | 10.26 % | 2.45 % | -10.24 % | -6.87 % | 14.97 % | 4.80 % | 12.07 % |
| Operating Margin | 52.64 % | 50.19 % | 51.39 % | 27.64 % | 13.06 % | 37.19 % | 36.79 % | 36.38 % |
| Return on Invested Capital | 3.88 % | 3.73 % | 3.70 % | 1.82 % | 0.92 % | 3.35 % | 3.44 % | 3.45 % |
| P/E | 21.1x | 22.2x | 16.0x | 23.2x | 37.4x | 16.9x | 24.1x | 25.3x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
National Health Investors Inc's Strategic Group Map
National Health Investors Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
National Health Investors Inc's trailing-12-month revenue growth of 23.9% and operating margin of 32.3% compares with an average of 19.7% growth and 29.4% margin across its 8 closest peers by combined growth, margin and ROIC -- National Health Investors Inc sits above that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
National Health Investors Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
National Health Investors Inc falls in the Dog quadrant: relative market share of 0.02x vs its largest competitor, in an industry growing revenue 2.4% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
National Health Investors Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 414 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 86.31 % vs industry average 28.42 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on National Health Investors Inc's dedicated Suppliers and Customers pages, not here.
National Health Investors Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
National Health Investors Inc falls in the Medium attractiveness / Medium strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
National Health Investors Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 5.2 points above the industry median.
- Return on equity 5.2 points above the industry aggregate.
- Latest-quarter revenue run-rate is accelerating (+12.3% annualized vs trailing 12 months).
Weaknesses
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.02x).
Opportunities
- Trades at a lower P/E than the industry average (22.1x vs 30.1x) despite a higher return on invested capital -- a possible re-rating opportunity.
Threats
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: see Methodology: SWOT Analysis.
National Health Investors Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| National Health Investors Inc | 0.86 | 0.86 | 0.79 |
| Welltower Inc | 1.37 | 3.09 | 0.36 |
| Ventas inc | 0.24 | 0.32 | 0.90 |
| Omega Healthcare Investors Inc | 0.59 | 1.92 | 0.05 |
| Healthpeak Properties Inc | 0.63 | 1.32 | 0.29 |
| American Healthcare Reit Inc | 0.40 | 1.54 | 0.57 |
Sign in to see all peers for National Health Investors Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
National Health Investors Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| National Health Investors Inc | Q2 2026 | +33.8 % | +50.9 % |
| Welltower Inc | Q3 2026 | +38.4 % | +47.0 % |
| Ventas inc | Q3 2026 | +23.0 % | -2.1 % |
| Omega Healthcare Investors Inc | Q2 2026 | +16.2 % | +170.3 % |
| Healthpeak Properties Inc | Q1 2026 | +7.1 % | +298.8 % |
| American Healthcare Reit Inc | Q2 2026 | +24.3 % | +207.4 % |
| PEERS TOTAL | +20.6 % | +143.4 % |
Sign in to see all peers for National Health Investors Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
National Health Investors Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| National Health Investors Inc | Q2 2026 | - | +171.5 % |
| Welltower Inc | Q3 2026 | +42.3 % | +144.7 % |
| Ventas inc | Q3 2026 | +27.2 % | +11.1 % |
| Omega Healthcare Investors Inc | Q2 2026 | - | -78.7 % |
| Healthpeak Properties Inc | Q1 2026 | - | +180.0 % |
| American Healthcare Reit Inc | Q2 2026 | +23.1 % | +92.2 % |
Sign in to see all peers for National Health Investors Inc .
National Health Investors Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| National Health Investors Inc | 5.83% | 6.48% | 10.81% |
| Welltower Inc | 2.51% | 2.52% | 3.78% |
| Ventas inc | 0.94% | 0.99% | 1.93% |
| Omega Healthcare Investors Inc | 8.76% | 8.79% | 16.44% |
| Healthpeak Properties Inc | 1.23% | 1.13% | 2.95% |
| American Healthcare Reit Inc | 2.28% | 1.99% | 3.67% |
Sign in to see all peers for National Health Investors Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
National Health Investors Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| National Health Investors Inc | 19.39 | 7.55 |
| Welltower Inc | 106.02 | 13.40 |
| Ventas inc | 167.87 | 6.81 |
| Omega Healthcare Investors Inc | 17.21 | 11.93 |
| Healthpeak Properties Inc | 62.63 | 4.91 |
| American Healthcare Reit Inc | 86.47 | 4.54 |
| PEERS AVERAGE | 61.51 | 9.19 |
Sign in to see all peers for National Health Investors Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.